when did glp 1 drugs come out With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss begins With FDA approval of Wegovy
Description
The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

The goal is to lose fat, preserve muscle, and improve long-term movement, living, and functioning

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight

Discover how GLP-1 drugs like semaglutide & tirzepatide are transforming obesity care with weight loss results rivaling bariatric surgery.
